In conclusion, our findings demonstrate that simultaneous suppression of JAK2 and PIM kinase activity by small molecule inhibitors is more effective than either agent alone in inhibiting the growth of MPN cells. The gene discussed is JAK2; the disease is myeloproliferative disorder.